Insmed, Inc. (INSM)
140.13
-3.44
(-2.40%)
USD |
NASDAQ |
Mar 06, 16:00
140.02
-0.11
(-0.08%)
After-Hours: 20:00
Insmed SG&A Expense (TTM) : 701.17M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Biogen, Inc. | 2.434B |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Amicus Therapeutics, Inc. | 383.49M |